UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 296

Sortiert nach

Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates

Journal of clinical microbiology, 2018-11, Vol.56 (11)

2018

Volltextzugriff (PDF)

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Clinical infectious diseases, 2023-07

2023

Volltextzugriff (PDF)

Combination Therapy for Treatment of Infections with Gram-Negative Bacteria

Clinical Microbiology Reviews, 2012-07, Vol.25 (3), p.450-470

2012

Volltextzugriff (PDF)

Comparison of 11 Phenotypic Assays for Accurate Detection of Carbapenemase-Producing Enterobacteriaceae

Journal of clinical microbiology, 2017-04, Vol.55 (4), p.1046-1055

2017

Volltextzugriff (PDF)

Antimicrobial Agents and Chemotherapy Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies

Antimicrobial agents and chemotherapy, 2023-06, Vol.67 (6), p.e0052623-e0052623

2023

Volltextzugriff (PDF)

Automated antimicrobial susceptibility testing and antimicrobial resistance genotyping using Illumina and Oxford Nanopore Technologies sequencing data among Enterobacteriaceae

Frontiers in microbiology, 2022-08, Vol.13, p.973605-973605

2022

Volltextzugriff (PDF)

Impact of a Prescriber-driven Antibiotic Time-out on Antibiotic Use in Hospitalized Patients

Clinical infectious diseases, 2019-04, Vol.68 (9), p.1581-1584

2019

Volltextzugriff (PDF)

Antimicrobial Stewardship

Infectious disease clinics of North America, 2011-03, Vol.25 (1), p.245-260

2011

Volltextzugriff (PDF)

Safety of influenza vaccination during pregnancy

American journal of obstetrics and gynecology, 2009-12, Vol.201 (6), p.547-552

2009

Volltextzugriff (PDF)

Chlorhexidine use in the neonatal intensive care unit: results from a national survey

Infection control and hospital epidemiology, 2010-08, Vol.31 (8), p.846

2010

Volltextzugriff (PDF)

Boosting of Voriconazole Levels With Omeprazole, A CYP450 2C19 Inhibitor

The Pediatric infectious disease journal, 2023-06, Vol.42 (6), p.485

2023

Volltextzugriff (PDF)

Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli

Journal of clinical microbiology, 2017-09, Vol.55 (9), p.2858-2864

2017

Volltextzugriff (PDF)

Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infection

Nature communications, 2022-08, Vol.13 (1), p.4459-4459, Article 4459

2022

Volltextzugriff (PDF)

Trends in Chlorhexidine Use in US Neonatal Intensive Care Units: Results From a Follow-Up National Survey

Infection control and hospital epidemiology, 2016-09, Vol.37 (9), p.1116-1118

2016

Volltextzugriff (PDF)

The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections

Clinical infectious diseases, 2017-04, Vol.64 (7), p.972-980

2017

Volltextzugriff (PDF)

Association of Adverse Events With Antibiotic Use in Hospitalized Patients

JAMA internal medicine, 2017-09, Vol.177 (9), p.1308

2017

Volltextzugriff (PDF)

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2021-04, Vol.72 (7), p.1109-1116

2021

Volltextzugriff (PDF)

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

Clinical infectious diseases, 2022-07, Vol.74 (12), p.2089-2114

2022

Volltextzugriff (PDF)

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2022-08, Vol.75 (2), p.187-212

2022

Volltextzugriff (PDF)

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2021-04, Vol.72 (7), p.e169-e183

2021

Volltextzugriff (PDF)

New Perspectives on Antimicrobial Agents: Cefiderocol

Antimicrobial agents and chemotherapy, 2021-07, Vol.65 (8), p.e0217120

2021

Volltextzugriff (PDF)

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Clinical infectious diseases, 2019-11, Vol.69 (11), p.2011-2014

2019

Volltextzugriff (PDF)

Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections

Clinical infectious diseases, 2023-05, Vol.76 (Suppl 2), p.S179-S193

2023

Volltextzugriff (PDF)

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials

BMC infectious diseases, 2011-06, Vol.11 (1), p.181-181, Article 181

2011

Volltextzugriff (PDF)

1 – 25 von 296

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(263)

Publikationsform

Sprache

Englisch
(296)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(228)
Life Sciences & Biomedicine
(227)
Infectious Diseases
(160)
Humans
(158)
Microbiology
(130)
Anti-Bacterial Agents - Therapeutic Use
(82)
Immunology
(77)
Antibiotics
(71)
Pediatrics
(60)
Anti-Bacterial Agents - Pharmacology
(57)
Microbial Sensitivity Tests
(48)
Child
(45)
Retrospective Studies
(45)
Male
(44)
Pharmacology & Pharmacy
(44)
Female
(43)
Adult
(32)
Public, Environmental & Occupational Health
(30)
Bacteremia - Drug Therapy
(27)
Infections
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Combination Therapy for Treatment of Infections with Gram-Negative Bacteria

Comparison of 11 Phenotypic Assays for Accurate Detection of Carbapenemase-Producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies

Automated antimicrobial susceptibility testing and antimicrobial resistance genotyping using Illumina and Oxford Nanopore Technologies sequencing data among Enterobacteriaceae

Impact of a Prescriber-driven Antibiotic Time-out on Antibiotic Use in Hospitalized Patients

Antimicrobial Stewardship

Safety of influenza vaccination during pregnancy

Chlorhexidine use in the neonatal intensive care unit: results from a national survey

Boosting of Voriconazole Levels With Omeprazole, A CYP450 2C19 Inhibitor

Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli

Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infection

Trends in Chlorhexidine Use in US Neonatal Intensive Care Units: Results From a Follow-Up National Survey

The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections

Association of Adverse Events With Antibiotic Use in Hospitalized Patients

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

New Perspectives on Antimicrobial Agents: Cefiderocol

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials

Suchergebnisse filtern